Treatment of Venous Thromboembolism – Effects of Different Therapeutic Strategies on Bleeding and Recurrence Rates and Considerations for Future Anticoagulant Management

Thrombosis Journal - United Kingdom
doi 10.1186/1477-9560-10-24
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Aspirin Given for Up to 2 Years After Initial Anticoagulant Treatment Reduces the Risk of Venous Thromboembolism Recurrence Without Increasing Risk of Major Bleeding

Evidence-based nursing
FundamentalsSkills
2012English

Pharmacokinetic and Pharmacodynamic Evaluation of Rivaroxaban: Considerations for the Treatment of Venous Thromboembolism

Thrombosis Journal
Hematology
2014English

Venous Thromboembolism: Prophylactic and Therapeutic Practice Guideline

South African Medical Journal
Medicine
2013English

A Descriptive Analysis of Patient Characteristics, Bleeding and Recurrence Risk Among U.S Veteran Patients Diagnosed With Venous Thromboembolism

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Adequate Management of Venous Thromboembolism

Circulation Journal
MedicineCardiovascular MedicineCardiology
2014English

Initiating and Managing Patients With Venous Thromboembolism on Anticoagulant Drugs: A Practical Overview

Seminars in Interventional Radiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2017English

The Management of Venous Thromboembolism

Canadian Pharmacists Journal
Pharmaceutical SciencePharmacy
2017English

Updates on Prophylaxis for Deep Venous Thrombosis and Venous Thromboembolism

Medical Research Archives
2019English

Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Journal of Vascular Surgery: Venous and Lymphatic Disorders
SurgeryCardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy